Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19767089 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma
Condition: Lymphoma, B Cell
Interventions: Drug: high dose methotrexate;   Drug: high dose cytarabine;   Procedure: radiotherapy

Indicates status has not been verified in more than two years